The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Varicella Prevention in the United States: A Review of Successes and Challenges
Abstract
OBJECTIVE. In 1995, the United States was the first country to introduce a universal 1-dose childhood varicella vaccination program. In 2006, the US varicella vaccine policy was changed to a routine 2-dose childhood program, with catchup vaccination for older children. The objective of this review was to summarize the US experience with the 1-dose varicella vaccination program, present the evidence considered for the policy change, and outline future challenges of the program. METHODS. We conducted a review of publications identified by searching PubMed for the terms “varicella,” “varicella vaccine,” and “herpes zoster.” The search was limited to US publications except for herpes zoster; we reviewed all published literature on herpes zoster incidence. RESULTS. A single dose of varicella vaccine was 80% to 85% effective in preventing disease of any severity and >95% effective in preventing severe varicella and had an excellent safety profile. The vaccination program reduced disease incidence by 57% to 90%, hospitalizations by 75% to 88%, deaths by >74%, and direct inpatient and outpatient medical expenditures by 74%. The decline of cases plateaued between 2003 and 2006, and outbreaks continued to occur, even among highly vaccinated school populations. Compared with children who received 1 dose, in 1 clinical trial, 2-dose vaccine recipients developed in a larger proportion antibody titers that were more likely to protect against breakthrough disease and had a 3.3-fold lower risk for breakthrough disease and higher vaccine efficacy. Two studies showed no increase in overall herpes zoster incidence, whereas 2 others showed an increase. CONCLUSIONS. A decade of varicella prevention in the United States has resulted in a dramatic decline in disease; however, even with high vaccination coverage, the effectiveness of 1 dose of vaccine did not generate sufficient population immunity to prevent community transmission. A 2-dose varicella vaccine schedule, therefore, was recommended for children in 2006. Data are inconclusive regarding an effect of the varicella vaccination program on herpes zoster epidemiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Summary of notifiable diseases--United States, 2002.
Groseclose, S. L., Brathwaite, W. S., Hall, P. A., Connor, F. J., Sharp, P., Anderson, W. J., Fagan, R. F., Javier, A. J., Jones, G. F., Nitschke, D. A., et al. (2004) · PubMed · Cited by 1,338
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547262006-001 · Cited by 1,079
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Self-citationPopulation-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.15.1605 · Cited by 652
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Seward, J. F. (2002) · JAMA · doi:10.1001/jama.287.5.606 · Cited by 557
Self-citation
Cited by
Pijpers, M. A. M., Tabbers, M. M., Benninga, M. A., & Berger, M. Y. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.127233 · Cited by 187
Metadata
- Authors
- Marin, M., Meissner, H. C., & Seward, J. F.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-09-01
- Volume
- 122
- Issue
- 3
- Pages
- e744-e751
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1993113905
- Cited by
- 269
- References
- 48
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Varicella Prevention in the United States: A Review of Successes and Challenges. https://app.cochat.ai/papers/10.1542/peds.2008-0567
- The paper
- Marin, M., Meissner, H. C., & Seward, J. F. (2008). Varicella Prevention in the United States: A Review of Successes and Challenges. Pediatrics. https://doi.org/10.1542/peds.2008-0567
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.